This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977
Title: Tetsuya Shiozaki: Innovator in Prostaglandin Derivatives
Introduction
Tetsuya Shiozaki is a notable inventor based in Misato, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel prostaglandin derivatives. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing healthcare.
Latest Patents
Tetsuya Shiozaki holds a patent for novel prostaglandin derivatives. The patent describes compounds with the formula: ##STR1## wherein A represents ##STR2##. In this formula, one of R.sub.3 and R.sub.4 represents a hydrogen atom while the other represents a lower alkyl group. Additionally, one of R.sub.5 and R.sub.6 represents a hydrogen atom and the other represents a hydroxyl group. Furthermore, one of R.sub.7 and R.sub.8 represents a hydrogen atom while the other represents a lower alkyl group. The compounds developed by Shiozaki exhibit excellent effects as prostaglandin E.sub.2 and prostaglandin F.sub.2.sub..alpha..
Career Highlights
Throughout his career, Tetsuya Shiozaki has been associated with Yamanouchi Pharmaceutical Company Ltd., where he has contributed to various research initiatives. His innovative work in prostaglandin derivatives has positioned him as a key figure in pharmaceutical research and development.
Collaborations
Tetsuya Shiozaki has collaborated with notable colleagues such as Masuo Murakami and Noriyoshi Inukai. These collaborations have further enhanced the research and development efforts within the pharmaceutical industry.
Conclusion
Tetsuya Shiozaki's contributions to the field of prostaglandin derivatives highlight his innovative approach to pharmaceutical research. His work continues to influence advancements in medical applications, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile